Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Current Hypertension Reports
Published in: Current Hypertension Reports 6/2012

01-12-2012 | Pediatric Hypertension (JT Flynn, Section Editor)

Progression of Prehypertension to Hypertension in Adolescents

Authors: Karen M. Redwine, Bonita Falkner

Published in: Current Hypertension Reports | Issue 6/2012

Login to get access

Abstract

In the 2004 report from the National High Blood Pressure (BP) Education Program Working Group on BP in Children and Adolescents, the term “high normal BP” was replaced with the designation “prehypertension”. It was proposed that BP levels that were higher than normal but did not reach the level of hypertension posed an increased risk for progression to hypertension. The overall intent of this description was to help identify children who were at the greatest risk for the development of hypertension. These are children and adolescents for whom targeted prevention programs are expected to be most beneficial. Following the 2004 report, the prehypertension condition has been examined and described in adolescents as well as adults. This review summarizes the knowledge that has been gained on prehypertension including clinical characteristics, rates of progression to hypertension, and evidence of cardiovascular pathology.
Literature
1.
National Heart L, Blood Institute. Report of the task force on blood pressure control in children. Pediatrics. 1977;59:797–820.
2.
Falkner B. Recent advances in pediatric hypertension. Journal of clinical hypertension (Greenwich, Conn;14(6):345.
3.
Chen X, Wang Y. Tracking of blood pressure from childhood to adulthood: a systematic review and meta-regression analysis. Circulation. 2008;117(25):3171–80.CrossRefPubMed
4.
Falkner B, Development of Blood Pressure Norms in Children. In Pediatric Hypertension, Second edition. Editors Flynn JT, Ingelfinger JR, and Portman RJ. New York: Humana Press; 201, pp 135-146.
5.
The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics 2004;114(2 Suppl 4th Report):555-76.
6.
Chobanian AV, Bakris GL, Black HR, et al. Seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension. 2003;42(6):1206–52.CrossRefPubMed
7.
Urbina E, Alpert B, Flynn J, et al. Ambulatory blood pressure monitoring in children and adolescents: recommendations for standard assessment: a scientific statement from the American Heart Association Atherosclerosis, Hypertension, and Obesity in Youth Committee of the council on cardiovascular disease in the young and the council for high blood pressure research. Hypertension. 2008;52(3):433–51.CrossRefPubMed
8.
White WB. Importance of aggressive blood pressure lowering when it may matter most. Am J Cardiol. 2007;100(3A):10J–6J.CrossRefPubMed
9.
Sorof JM, Cardwell G, Franco K, Portman RJ. Ambulatory blood pressure and left ventricular mass index in hypertensive children. Hypertension. 2002;39(4):903–8.CrossRefPubMed
10.
Chamontin B, Amar J, Barthe P, Salvador M. Blood pressure measurements and left ventricular mass in young adults with arterial hypertension screened at high school check-up. J Hum Hypertens. 1994;8(5):357–61.PubMed
11.
Lurbe E, Torro I, Alvarez V, et al. Prevalence, persistence, and clinical significance of masked hypertension in youth. Hypertension. 2005;45(4):493–8.CrossRefPubMed
12.
McNiece KL, Gupta-Malhotra M, Samuels J, et al. Left ventricular hypertrophy in hypertensive adolescents: analysis of risk by 2004 National High Blood Pressure Education Program Working Group staging criteria. Hypertension. 2007;50(2):392–5.CrossRefPubMed
13.
Stabouli S, Kotsis V, Toumanidis S, Papamichael C, Constantopoulos A, Zakopoulos N. White-coat and masked hypertension in children: association with target-organ damage. Pediatr Nephrol. 2005;20(8):1151–5.CrossRefPubMed
14.
Lande MB, Carson NL, Roy J, Meagher CC. Effects of childhood primary hypertension on carotid intima media thickness: a matched controlled study. Hypertension. 2006;48(1):40–4.CrossRefPubMed
15.
Munter PHJ, Cutler JA, Wildman RP, Welton PK. Trends in blood pressure among children and adolescents. JAMA. 2004;291:2107–13.CrossRef
16.
Din-Dzietham R, Liu Y, Bielo MV, Shamsa F. High blood pressure trends in children and adolescents in national surveys, 1963 to 2002. Circulation. 2007;116(13):1488–96.CrossRefPubMed
17.
Sorof JM, Lai D, Turner J, Poffenbarger T, Portman RJ. Overweight, ethnicity, and the prevalence of hypertension in school-aged children. Pediatrics. 2004;113(3 Pt 1):475–82.CrossRefPubMed
18.
• McNiece KL, Poffenbarger TS, Turner JL, Franco KD, Sorof JM, Portman RJ. Prevalence of hypertension and pre-hypertension among adolescents. J Pediatr. 2007;150(6):640–4. 4 e1. The authors provide data, based on school BP screening, to demonstrate the prevalence of prehypertension among healthy adolescents.CrossRefPubMed
19.
• Acosta AA, Samuels JA, Portman RJ, Redwine KM. Prevalence of persistent prehypertension in adolescents. J Pediatr. 2011. The authors provide data on the prevalence of prehypertension verified on more than one BP measurement.
20.
Genovesi S, Giussani M, Pieruzzi F, et al. Results of blood pressure screening in a population of school-aged children in the province of Milan: role of overweight. J Hypertens. 2005;23(3):493–7.CrossRefPubMed
21.
Antal M, Regoly-Merei A, Nagy K, et al. Representative study for the evaluation of age- and gender-specific anthropometric parameters and blood pressure in an adolescent Hungarian population. Ann Nutr Metab. 2004;48(5):307–13.CrossRefPubMed
22.
Kardas P, Kufelnicka M, Herczynski D. Prevalence of arterial hypertension in children aged 9-14 years, residents of the city of Lodz. Kardiol Pol. 2005;62(3):211–6. discussion 6-7.PubMed
23.
Saleh EA, Mahfouz AA, Tayel KY, Naguib MK, Bin-al-Shaikh NM. Hypertension and its determinants among primary-school children in Kuwait: an epidemiological study. East Mediterr Health J. 2000;6(2–3):333–7.PubMed
24.
• Hansen ML, Gunn PW, Kaelber DC. Underdiagnosis of hypertension in children and adolescents. JAMA. 2007;298(8):874–9. The prevalence of prehypertension based on at least three separate measurements in children from 3 to 18 years in pediatric primary care clinics is reported. Data were derived from electronic medical records. The focus of this report was to verify that high BP, both hypertension and prehypertension, is not recognized by clinicians.CrossRefPubMed
25.
Chiolero A, Paccaud F, Bovet P. Pre-hypertension and hypertension among adolescents of Switzerland. J Pediatr. 2007;151(6):e24–5.CrossRefPubMed
26.
Falkner B, Gidding SS, Portman R, Rosner B. Blood pressure variability and classification of prehypertension and hypertension in adolescence. Pediatrics. 2008;122(2):238–42.CrossRefPubMed
27.
Jago R, Harrell JS, McMurray RG, Edelstein S, El Ghormli L, Bassin S. Prevalence of abnormal lipid and blood pressure values among an ethnically diverse population of eighth-grade adolescents and screening implications. Pediatrics. 2006;117(6):2065–73.CrossRefPubMed
28.
Zhu H, Yan W, Ge D, et al. Cardiovascular characteristics in American youth with prehypertension. Am J Hypertens. 2007;20(10):1051–7.CrossRefPubMed
29.
Bao W, Threefoot SA, Srinivasan SR, Berenson GS. Essential hypertension predicted by tracking of elevated blood pressure from childhood to adulthood: the Bogalusa Heart Study. Am J Hypertens. 1995;8(7):657–65.CrossRefPubMed
30.
•• Redwine KM, Acosta AA, Poffenbarger T, Portman RJ, Samuels J. Development of hypertension in adolescents with pre-hypertension. J Pediatr. 2012;160(1):98–103. The authors provide the first report on progression from prehypertension to hypertension in adolescents that is based on prospective data.CrossRefPubMed
31.
Falkner B. Prehypertension in adolescents: how high is the risk for hypertension? J Pediatr. 2012;160(1):7–9.CrossRefPubMed
32.
Vasan RS, Larson MG, Leip EP, Kannel WB, Levy D. Assessment of frequency of progression to hypertension in non-hypertensive participants in the Framingham Heart Study: a cohort study. Lancet. 2001;358(9294):1682–6.CrossRefPubMed
33.
Richey PA, Disessa TG, Hastings MC, Somes GW, Alpert BS, Jones DP. Ambulatory blood pressure and increased left ventricular mass in children at risk for hypertension. J Pediatr. 2008;152(3):343–8.CrossRefPubMed
34.
Stabouli S, Kotsis V, Rizos Z, et al. Left ventricular mass in normotensive, prehypertensive and hypertensive children and adolescents. Pediatr Nephrol. 2009;24(8):1545–51.CrossRefPubMed
35.
Drukteinis JS, Roman MJ, Fabsitz RR, et al. Cardiac and systemic hemodynamic characteristics of hypertension and prehypertension in adolescents and young adults: the Strong Heart Study. Circulation. 2007;115(2):221–7.CrossRefPubMed
36.
Tu W, Eckert GJ, DiMeglio LA, Yu Z, Jung J, Pratt JH. Intensified effect of adiposity on blood pressure in overweight and obese children. Hypertension. 2011;58(5):818–24.CrossRefPubMed
37.
Falkner B DS, Keith SW, Gidding SS Both high risk blood pressure and obesity increase the risk for left ventricular hypertrophy in African American adolescents. The Journal of pediatrics 2012(in press).
38.
Urbina EM, Khoury PR, McCoy C, Daniels SR, Kimball TR, Dolan LM. Cardiac and vascular consequences of pre-hypertension in youth. J Clin Hypertens (Greenwich). 2011;13(5):332–42.CrossRef
39.
Daniels SR, Pratt CA, Hayman LL. Reduction of risk for cardiovascular disease in children and adolescents. Circulation. 2011;124(15):1673–86.CrossRefPubMed
40.
Julius S, Nesbitt SD, Egan BM, et al. Feasibility of treating prehypertension with an angiotensin-receptor blocker. N Engl J Med. 2006;354(16):1685–97.CrossRefPubMed
Metadata
Title
Progression of Prehypertension to Hypertension in Adolescents
Authors
Karen M. Redwine
Bonita Falkner
Publication date
01-12-2012
Publisher
Current Science Inc.
Published in
Current Hypertension Reports / Issue 6/2012
Print ISSN: 1522-6417
Electronic ISSN: 1534-3111
DOI
https://doi.org/10.1007/s11906-012-0299-y

Other articles of this Issue 6/2012

Current Hypertension Reports 6/2012 Go to the issue

Mediators, Mechanisms, and Pathways in Tissue Injury (B Rothermel, Section Editor)

Cytoskeletal Regulation of TRPC Channels in the Cardiorenal System

Special Situations in the Management of Hypertension (T Kotchen, Section Editor)

The Ubiquitous Mineralocorticoid Receptor: Clinical Implications

Special Situations in the Management of Hypertension (T Kotchen, Section Editor)

Hypertension and Mild Cognitive Impairment

Mediators, Mechanisms, and Pathways in Tissue Injury (B Rothermel, Section Editor)

Mechanisms and Consequences of Inflammatory Signaling in the Myocardium

Hot Topic

Neurogenic Hypertension: Revelations from Genome-Wide Gene Expression Profiling

Pediatric Hypertension (JT Flynn, Section Editor)

Update on Imaging for Suspected Renovascular Hypertension in Children and Adolescents
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits